← FDA Drug Approvals (Drugs@FDA)
ALYQ
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2022-10-12
Drug application
- FDA Application #
ANDA216932- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ALYQ
- Generic name
- TADALAFIL
- Active ingredients
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS INC
- Manufacturer
- Teva Pharmaceuticals, Inc.
- First approval
- 2022-10-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown